Geode Capital Management, LLC Akouos, Inc. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.6 - $5.16 $42,941 - $85,222	-16,516 Reduced 7.85%	193,842 $1.31 Million
Q2 2022 Aug 12, 2022	SELL	$2.46 - $5.2 $456,499 - $964,958	-185,569 Reduced 46.87%	210,358 $986,000
Q1 2022 May 13, 2022	BUY	$4.16 - $9.08 $38,076 - $83,109	9,153 Added 2.37%	395,927 $1.88 Million
Q4 2021 Feb 11, 2022	BUY	$7.65 - $11.38 $97,659 - $145,277	12,766 Added 3.41%	386,774 $3.29 Million
Q3 2021 Nov 12, 2021	BUY	$9.93 - $13.59 $298,744 - $408,855	30,085 Added 8.75%	374,008 $4.34 Million
Q2 2021 Aug 13, 2021	SELL	$11.87 - $15.96 $34,802 - $46,794	-2,932 Reduced 0.85%	343,923 $4.32 Million
Q1 2021 May 12, 2021	BUY	$13.87 - $21.04 $1.52 Million - $2.31 Million	109,580 Added 46.18%	346,855 $4.81 Million
Q4 2020 Feb 12, 2021	BUY	$17.03 - $22.45 $215,480 - $284,059	12,653 Added 5.63%	237,275 $4.71 Million
Q3 2020 Nov 13, 2020	BUY	$19.3 - $26.92 $4.34 Million - $6.05 Million	224,622 New	224,622 $5.14 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.